By continuing to use our site, you agree to our Private Policy and Terms of Use.
Over a 20-year period, a ban could lower health care costs among all adult smokers by about $1.62 billion, a recent study found.
The ruling is a significant setback for the anti-abortion movement in what was the first major Supreme Court case on reproductive rights since the court’s conservative majority overturned Roe v. Wade in 2022.
The maker of Truvada and Descovy has not ever paid licensing frees for PrEP, a patented process discovered by scientists at the CDC.
Gilead Sciences Inc. prepared to expand its reach further beyond AIDS drugs Monday after federal regulators approved the biotech drug maker's signature anti-HIV therapy as a hepatitis B treatment.
The vice president warned that the ruling is not a cause for celebration in a country where Republicans are attacking bodily autonomy rights.
Civil rights groups say the FDA's new guidelines are 'unacceptable' for retaining restrictions on blood donations by sexually active gay and bisexual men. And for transgender donors, there's also a change in the works.
Admiral Rachel Levine and Dr. Jesse Ehrenfeld address puberty blockers, FDA challenges, and the power of community engagement to combat misinformation in a crucial dialogue on trans health care.
AHF's recent complaint against Gilead says less about the drug company and more about its controversial leader.
Musicians Tegan and Sara lead the pack of accomplished leaders in politics, sports, science, religion, and the arts. Meet the architects of the next decade.
These lesbian, gay, bisexual, trans, and queer students are in for a great year ahead!
